Skip to content

IPA/ Erasmus MC Pompe Survey

IPA/ Erasmus MC Pompe Survey - IPA/ Erasmus MC Pompe Survey

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53084
Enrollment
500
Registered
2008-11-11
Start date
2009-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acid maltase deficiency glycogen storage disease type 2 Pompe Disease

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: All patients and/or their parents/legal guardian who have signed the IPA/ Erasmus MC Pompe Survey patient information and authorization form and have a confirmed diagnosis of Pompe disease are eligible for inclusion.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Effect of treatment with enzyme replacement therapy, quality of life, clinical course For patients older than 16: Pompe's disease specific questionnaire, Rotterdam 9-item Handicap scale, Fatigue severity scale, SF-36v2 quality of life questionnaire, Rash-built Pompe-specific Activity Scale, EQ-5D and VAS. For patients younger than 16:Pompe's disease specific questionnaire,CHAQ en PedsQL (generic, neuromuscular and fatigue module). For alle of these questionnaires there will be a parent and child version available.

Countries

Netherlands

Contacts

Public ContactM.E. Kruijshaar

The survey is a joint collaboration between the International Pompe Association and Erasmus MC

pompe.survey@erasmusmc.nl+31(0)107031945

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026